The 4th International Congress and Exhibition Pharma Uzbekistan & Central Asia is set to take place from September 24-25, 2025, in Tashkent, Uzbekistan. This unique platform brings together over 400 top-tier executives from the pharmaceutical industry, including senior executives of investment projects, government officials, regulators, and technology providers. The event aims to discuss major investment projects and efficiency boosting options for pharmaceutical production.

The congress will feature more than 20 presentations by C-suite executives and industry experts from leading companies. Additionally, there will be 35 flagship investment initiatives discussed, offering new horizons for the development of the pharmaceutical market in Uzbekistan and plans for constructing new plants. A significant focus will be on dialogue between the government and business sectors, exploring the prospects and goals of the pharmaceutical market in Uzbekistan and Central Asia.

Participants will have access to a full day of networking opportunities, with over 30 hours dedicated to business and informal interactions. These include one-on-one meetings, business lunches, coffee breaks, a welcome cocktail, and an exclusive exhibition showcasing technologies and services from global leaders.

Among the speakers are high-profile figures such as Oybek Elmuratov from the Ministry of Health of Uzbekistan and Shadiya Kurmukova from Baxtteks-Farm. Other notable attendees include Sarkor Isonbayev from Dentafill Plyus LLC and Matyoqub Toraboyev from Grand Pharm Logistics Hub.

The congress also highlights major investment projects in various sectors of pharmaceutical production, including medical preparations in the form of injections and infusions, production of substances and medical preparations in the form of pills and capsules, construction of production facilities for tablets, capsules, injectables, infusions preparations, suspensions, syrups, and solutions. Other initiatives include the establishment of the Tashkent Pharma Park innovative R&D pharmaceutical cluster (Phase 1) and production of oncotherapeutic preparations.

This event promises to be a valuable platform for sharing knowledge and experiences in the pharmaceutical field. It offers a unique opportunity for industry leaders to network, discuss key challenges and opportunities, and explore new horizons in the pharmaceutical market.